MUX Fundamental Analysis - MCEWEN INC

Fundamental Rating

Overall MUX gets a fundamental rating of 3 out of 10. We evaluated MUX against 154 industry peers in the Metals & Mining industry. Both the profitability and financial health of MUX have multiple concerns. MUX has a decent growth rate and is not valued too expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year MUX has reported negative net income.

In the past year MUX had a positive cash flow from operations.

In the past 5 years MUX reported 4 times negative net income.

In the past 5 years MUX reported 4 times negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -1.59%, MUX perfoms like the industry average, outperforming 49.67% of the companies in the same industry.

With a Return On Equity value of -2.44%, MUX perfoms like the industry average, outperforming 49.67% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-1.59%
ROE	-2.44%
ROIC	N/A

ROA(3y)-4.5%

ROA(5y)-10.95%

ROE(3y)-7.65%

ROE(5y)-15.95%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

MUX has a Gross Margin (18.34%) which is comparable to the rest of the industry.

MUX's Gross Margin has improved in the last couple of years.

MUX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	18.34%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y18.18%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

MUX does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for MUX has been increased compared to 1 year ago.

MUX has more shares outstanding than it did 5 years ago.

MUX has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.05, we must say that MUX is in the distress zone and has some risk of bankruptcy.

With a Altman-Z score value of 0.05, MUX is not doing good in the industry: 88.24% of the companies in the same industry are doing better.

A Debt/Equity ratio of 0.26 indicates that MUX is not too dependend on debt financing.

MUX has a worse Debt to Equity ratio (0.26) than 62.09% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.26
Debt/FCF	N/A
Altman-Z	0.05

ROIC/WACCN/A

WACC8.64%

2.3 Liquidity

MUX has a Current Ratio of 2.10. This indicates that MUX is financially healthy and has no problem in meeting its short term obligations.

MUX has a Current ratio of 2.10. This is comparable to the rest of the industry: MUX outperforms 41.18% of its industry peers.

MUX has a Quick Ratio of 1.58. This is a normal value and indicates that MUX is financially healthy and should not expect problems in meeting its short term obligations.

MUX has a Quick ratio (1.58) which is in line with its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.1
Quick Ratio	1.58

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 61.80% over the past year.

The Revenue for MUX has decreased by -16.62% in the past year. This is quite bad

MUX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.32% yearly.

EPS 1Y (TTM)61.8%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%75%

Revenue 1Y (TTM)-16.62%

Revenue growth 3Y8.53%

Revenue growth 5Y8.32%

Sales Q2Q%-3.28%

3.2 Future

MUX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 113.90% yearly.

MUX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.41% yearly.

EPS Next Y165.49%

EPS Next 2Y112.91%

EPS Next 3Y113.9%

EPS Next 5YN/A

Revenue Next Year-3.04%

Revenue Next 2Y9.35%

Revenue Next 3Y11.41%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MUX. In the last year negative earnings were reported.

The Price/Forward Earnings ratio is 11.85, which indicates a very decent valuation of MUX.

MUX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MUX is cheaper than 77.78% of the companies in the same industry.

MUX is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.59, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	11.85

4.2 Price Multiples

MUX's Enterprise Value to EBITDA ratio is in line with the industry average.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	84.58

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

MUX's earnings are expected to grow with 113.90% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y112.91%

EPS Next 3Y113.9%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for MUX!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MCEWEN INC

NYSE:MUX (11/28/2025, 7:49:27 PM)

After market: 19.15 +0.54 (+2.9%)

18.61

+0.75 (+4.2%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryMetals & Mining

Earnings (Last)11-05 2025-11-05/amc

Earnings (Next)03-12 2026-03-12/bmo

Inst Owners43.82%

Inst Owner Change2.64%

Ins Owners0.55%

Ins Owner Change0.82%

Market Cap1.01B

Revenue(TTM)166.45M

Net Income(TTM)-11.92M

Analysts80

Price Target23.66 (27.14%)

Short Float %17.16%

Short Ratio4.59

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)193.94%

Min EPS beat(2)-106.19%

Max EPS beat(2)494.06%

EPS beat(4)1

Avg EPS beat(4)46.88%

Min EPS beat(4)-197.03%

Max EPS beat(4)494.06%

EPS beat(8)3

Avg EPS beat(8)8.28%

EPS beat(12)5

Avg EPS beat(12)-40.66%

EPS beat(16)6

Avg EPS beat(16)-62.37%

Revenue beat(2)0

Avg Revenue beat(2)-13.91%

Min Revenue beat(2)-22.09%

Max Revenue beat(2)-5.74%

Revenue beat(4)1

Avg Revenue beat(4)-8.56%

Min Revenue beat(4)-22.09%

Max Revenue beat(4)3.09%

Revenue beat(8)5

Avg Revenue beat(8)-1.07%

Revenue beat(12)6

Avg Revenue beat(12)-3.06%

Revenue beat(16)6

Avg Revenue beat(16)-5.73%

PT rev (1m)49.68%

PT rev (3m)51.51%

EPS NQ rev (1m)-36.07%

EPS NQ rev (3m)56%

EPS NY rev (1m)60.8%

EPS NY rev (3m)228.16%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)19.57%

Revenue NY rev (1m)7.08%

Revenue NY rev (3m)14.96%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	11.85
P/S	6.09
P/FCF	N/A
P/OCF	397.61
P/B	2.07
P/tB	2.07
EV/EBITDA	84.58

EPS(TTM)-0.34

EYN/A

EPS(NY)1.57

Fwd EY8.44%

FCF(TTM)-0.87

FCFYN/A

OCF(TTM)0.05

OCFY0.25%

SpS3.06

BVpS8.97

TBVpS8.97

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.59%
ROE	-2.44%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	18.34%
FCFM	N/A

ROA(3y)-4.5%

ROA(5y)-10.95%

ROE(3y)-7.65%

ROE(5y)-15.95%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y18.18%

F-Score4

Asset Turnover0.22

Health

		Industry Rank	Sector Rank
Debt/Equity	0.26
Debt/FCF	N/A
Debt/EBITDA	10.66
Cap/Depr	181.37%
Cap/Sales	29.99%
Interest Coverage	N/A
Cash Conversion	21.58%
Profit Quality	N/A
Current Ratio	2.1
Quick Ratio	1.58
Altman-Z	0.05

F-Score4

WACC8.64%

ROIC/WACCN/A

Cap/Depr(3y)153.99%

Cap/Depr(5y)131.29%

Cap/Sales(3y)27.62%

Cap/Sales(5y)24.24%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)61.8%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%75%

EPS Next Y165.49%

EPS Next 2Y112.91%

EPS Next 3Y113.9%

EPS Next 5YN/A

Revenue 1Y (TTM)-16.62%

Revenue growth 3Y8.53%

Revenue growth 5Y8.32%

Sales Q2Q%-3.28%

Revenue Next Year-3.04%

Revenue Next 2Y9.35%

Revenue Next 3Y11.41%

Revenue Next 5YN/A

EBIT growth 1Y-1953.46%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year159.29%

EBIT Next 3Y101.59%

EBIT Next 5YN/A

FCF growth 1Y57.43%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y104.9%

OCF growth 3YN/A

OCF growth 5YN/A

MCEWEN INC / MUX FAQ

What is the ChartMill fundamental rating of MCEWEN INC (MUX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to MUX.

Can you provide the valuation status for MCEWEN INC?

ChartMill assigns a valuation rating of 4 / 10 to MCEWEN INC (MUX). This can be considered as Fairly Valued.

What is the profitability of MUX stock?

MCEWEN INC (MUX) has a profitability rating of 2 / 10.

What is the financial health of MCEWEN INC (MUX) stock?

The financial health rating of MCEWEN INC (MUX) is 3 / 10.

MCEWEN INC (MUX) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

MCEWEN INC / MUX FAQ

What is the ChartMill fundamental rating of MCEWEN INC (MUX) stock?

Can you provide the valuation status for MCEWEN INC?

What is the profitability of MUX stock?

What is the financial health of MCEWEN INC (MUX) stock?